| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.91B | 115.84B | 119.17B | 102.25B | 59.44B | 47.72B |
| Gross Profit | 59.79B | 56.78B | 52.00B | 48.59B | 44.70B | 42.49B |
| EBITDA | 20.54B | 25.81B | 12.86B | 14.80B | 22.19B | 19.20B |
| Net Income | 14.91B | 20.54B | 8.84B | 10.63B | 17.43B | 14.30B |
Balance Sheet | ||||||
| Total Assets | 2.09T | 2.09T | 2.06T | 1.96T | 1.92T | 1.73T |
| Cash, Cash Equivalents and Short-Term Investments | 446.59B | 156.06B | 230.49B | 116.51B | 156.98B | 194.67B |
| Total Debt | 692.29B | 663.58B | 662.56B | 568.66B | 502.06B | 400.86B |
| Total Liabilities | 1.96T | 1.97T | 1.95T | 1.84T | 1.81T | 1.63T |
| Stockholders Equity | 124.32B | 127.83B | 115.16B | 112.07B | 111.38B | 99.82B |
Cash Flow | ||||||
| Free Cash Flow | 12.98B | -71.79B | 52.76B | -67.15B | 37.49B | 49.00B |
| Operating Cash Flow | 15.35B | -69.65B | 54.94B | -65.30B | 38.95B | 50.13B |
| Investing Cash Flow | -2.10B | 86.19B | -45.42B | 76.23B | -31.89B | -45.27B |
| Financing Cash Flow | -12.78B | -15.50B | -9.81B | -12.85B | -4.82B | -5.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$162.16B | 16.55 | 11.25% | 3.61% | -4.35% | 21.22% | |
72 Outperform | C$378.40B | 17.03 | 15.95% | 2.58% | 1.99% | 22.50% | |
71 Outperform | C$78.78B | 17.13 | 13.77% | 2.64% | 6.36% | 7.80% | |
70 Outperform | C$140.46B | 14.19 | 15.24% | 3.07% | -3.32% | 27.25% | |
68 Neutral | C$139.41B | 14.47 | 11.06% | 4.32% | -5.52% | 47.19% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$266.99B | 17.57 | 11.85% | 3.34% | -11.69% | -11.99% |